Embryo morphokinetic score is associated with biomarkers of developmental competence and implantation.


Journal

Journal of assisted reproduction and genetics
ISSN: 1573-7330
Titre abrégé: J Assist Reprod Genet
Pays: Netherlands
ID NLM: 9206495

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 15 12 2020
accepted: 18 03 2021
pubmed: 7 4 2021
medline: 30 12 2021
entrez: 6 4 2021
Statut: ppublish

Résumé

To study embryo morphokinetics in relation to release in spent media of molecules with possible roles in development and implantation (miR-20a, miR-30c, and sHLA-G). Data were obtained from embryos generated in standard IVF and ICSI cycles. The Eeva system was used for embryo assessment, based on early morphokinetic parameters and producing a score (1-5, best-worst) corresponding to higher/medium/lower chances of development to blastocyst. miRNAs - mm miR-20a-5p and miR-30c-5p - and sHLA-G were quantified in 25 μl of spent blastocyst media (SBM) collected before vitrification or transfer. Statistical analyses were performed applying Kolmogorov-Smirnov, Shapiro-Wilk, and Spearman's correlation coefficient tests, where appropriate. SBM were collected from a total of 172 viable blastocysts. Their analysis showed that concentration of miR-20a was progressively lower as Eeva score increased and probability of development to blastocyst decreased (P = 0.016). The opposite trend was observed in the case of miR-30c, i.e., concentration was higher as score increased and chances of development to blastocyst decreased (P = 0.004). Analysis of sHLA-G revealed a negative correlation with Eeva score, i.e., levels were progressively lower as Eeva score increased and probability of development to blastocyst decreased (R = - 0.388, N = 141, P = 0.001). Our data suggest that morphokinetic algorithms that predict development to blastocyst stage, in fact, also identify embryos with molecular and cellular profiles more consistent with developmental functions.

Identifiants

pubmed: 33821429
doi: 10.1007/s10815-021-02162-9
pii: 10.1007/s10815-021-02162-9
pmc: PMC8324755
doi:

Substances chimiques

Algipore 0
Biomarkers 0
Bone Substitutes 0
Culture Media 0
HLA-G Antigens 0
MIRN20a microRNA, human 0
MIRN30C2 microRNA, human 0
MicroRNAs 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1737-1743

Subventions

Organisme : Merck Serono S.p.A., Italy, an affiliate of Merck KGaA, Darmstadt, Germany
ID : N.A.

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Reprod Biomed Online. 2020 Mar;40(3):347-354
pubmed: 32057674
Dev Biol. 2009 Feb 15;326(2):431-43
pubmed: 19073166
Hum Reprod. 2015 Feb;30(2):276-83
pubmed: 25527613
Fertil Steril. 2018 Sep;110(4):703-709
pubmed: 30196967
Zygote. 2019 Apr;27(2):78-81
pubmed: 30871646
Nat Rev Mol Cell Biol. 2019 Jan;20(1):21-37
pubmed: 30108335
Front Genet. 2019 Apr 05;10:315
pubmed: 31024625
Front Immunol. 2014 May 13;5:198
pubmed: 24860568
Fertil Steril. 2016 Jul;106(1):119-126.e2
pubmed: 27037460
Eur J Immunol. 2002 Feb;32(2):311-5
pubmed: 11807769
Hum Reprod. 2019 Sep 29;34(9):1746-1761
pubmed: 31419301
Reprod Biomed Online. 2004 Jul;9(1):74-8
pubmed: 15257824
Hum Reprod. 2016 Oct;31(10):2231-44
pubmed: 27609980
Reprod Biomed Online. 2013 May;26(5):477-85
pubmed: 23518033
Reprod Biomed Online. 2014 Aug;29(2):156-8
pubmed: 24912418
Fertil Steril. 2005 Jan;83(1):30-6
pubmed: 15652883
Hum Reprod Open. 2020 Mar 19;2020(2):hoaa008
pubmed: 32206731
Hum Reprod. 2011 Oct;26(10):2658-71
pubmed: 21828117
Fertil Steril. 2013 Nov;100(5):1303-9
pubmed: 23993930
Fertil Steril. 2014 Mar;101(3):699-704
pubmed: 24424365
Cells. 2019 Dec 04;8(12):
pubmed: 31817143
Front Immunol. 2020 Jan 14;10:2982
pubmed: 31993049
Hum Reprod. 2018 Jan 1;33(1):23-31
pubmed: 29149327
Hum Reprod. 2010 Jul;25(7):1691-8
pubmed: 20488801
Cell Mol Life Sci. 2011 Feb;68(3):341-52
pubmed: 21080028
Fertil Steril. 2014 Nov;102(5):1295-1300.e2
pubmed: 25225070
Development. 2016 Feb 15;143(4):635-47
pubmed: 26718009
Fertil Steril. 2016 Jan;105(1):225-35.e1-3
pubmed: 26453979
Reprod Biomed Online. 2017 Feb;34(2):137-146
pubmed: 27938863
Fertil Steril. 2012 Dec;98(6):1458-63
pubmed: 22925687
Hum Mol Genet. 2018 Jul 15;27(14):2573-2585
pubmed: 29688390
Hum Reprod. 2005 Jan;20(1):138-46
pubmed: 15498780
Fertil Steril. 2013 Aug;100(2):412-9.e5
pubmed: 23721712

Auteurs

Giovanni Coticchio (G)

9.baby Family and Fertility Center, Via Dante, 15, 40125, Bologna, Italy. giovanni.coticchio@nove.baby.

Francesca Pennetta (F)

9.baby Family and Fertility Center, Via Dante, 15, 40125, Bologna, Italy.
Simple Departmental Operative Unit, Reproductive Pathophysiology, Anastasia Guerriero Hospital, Marcianise, Caserta, Italy.

Roberta Rizzo (R)

Section of Microbiology and Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.

Nicoletta Tarozzi (N)

9.baby Family and Fertility Center, Via Dante, 15, 40125, Bologna, Italy.

Marco Nadalini (M)

9.baby Family and Fertility Center, Via Dante, 15, 40125, Bologna, Italy.

Giovanna Orlando (G)

Merck Serono S.p.A., Rome, Italy.

Chiara Centonze (C)

Merck Serono S.p.A., Rome, Italy.

Giorgia Gioacchini (G)

Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy.

Andrea Borini (A)

9.baby Family and Fertility Center, Via Dante, 15, 40125, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH